Literature DB >> 6593433

Linkage studies in autosomal dominant facioscapulohumeral muscular dystrophy.

G Padberg, A W Eriksson, W S Volkers, L Bernini, E Van Loghem, P Meera Khan, L E Nijenhuis, J C Pronk, G M Schreuder.   

Abstract

Linkage studies were undertaken in 120 individuals from 10 kindreds with autosomal dominant facioscapulohumeral muscular dystrophy using 35 different marker genes. No linkage was found. The highest lod score was 1.438 for the immunoglobulin heavy chain gene cluster (IGH) at a recombination fraction of 0.2. IGH is located on the long arm of chromosome 14. Based on scores of other marker genes and on a recombination map of chromosome 14, the probability that the gene for facioscapulohumeral muscular dystrophy is located on chromosome 14 is estimated to be approximately 6%.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6593433     DOI: 10.1016/0022-510x(84)90090-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  A closely linked DNA marker for facioscapulohumeral disease on chromosome 4q.

Authors:  M Upadhyaya; P W Lunt; M Sarfarazi; W Broadhead; J Daniels; M Owen; P S Harper
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

2.  A clinically homogeneous group of families with facioscapulohumeral (Landouzy-Déjérine) muscular dystrophy: linkage analysis of six autosomes.

Authors:  S J Jacobsen; E S Diala; B V Dorsey; M B Rising; R Graveline; K Falls; P Schultz; C Hogan; K Rediker; C D'Amico
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

3.  A genetic linkage study of facioscapulohumeral (Landouzy-Déjérine) disease with 24 polymorphic DNA probes.

Authors:  M Upadhyaya; M Sarfarazi; P W Lunt; W Broadhead; P S Harper
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

4.  Linkage analysis of French families with facioscapulohumeral muscular dystrophy.

Authors:  G Lucotte; S Berriche; M Fardeau
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

5.  An exclusion map for facioscapulohumeral (Landouzy-Déjérine) disease.

Authors:  M Sarfarazi; M Upadhyaya; G Padberg; M Pericak-Vance; T Siddique; G Lucotte; P Lunt
Journal:  J Med Genet       Date:  1989-08       Impact factor: 6.318

6.  RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy.

Authors:  Lindsay M Wallace; Jian Liu; Jacqueline S Domire; Sara E Garwick-Coppens; Susan M Guckes; Jerry R Mendell; Kevin M Flanigan; Scott Q Harper
Journal:  Mol Ther       Date:  2012-04-17       Impact factor: 11.454

7.  Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients.

Authors:  Dimitrios Konstantonis; Kyriaki Kekou; Petros Papaefthymiou; Heleni Vastardis; Nikoleta Konstantoni; Maria Athanasiou; Maria Svingou; Anastasia Margariti; Angeliki Panousopoulou
Journal:  Children (Basel)       Date:  2022-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.